Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) (TSE:I) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,000 shares, an increase of 100.0% from the February 29th total of 500 shares. Based on an average daily trading volume, of 4,400 shares, the short-interest ratio is currently 0.2 days.

Intellipharmaceutics International Stock Up 18.6 %

Intellipharmaceutics International stock traded up $0.01 during trading hours on Thursday, reaching $0.07. 103 shares of the company’s stock were exchanged, compared to its average volume of 16,541. Intellipharmaceutics International has a twelve month low of $0.00 and a twelve month high of $0.11. The firm’s 50 day simple moving average is $0.05 and its 200 day simple moving average is $0.06. The firm has a market capitalization of $2.35 million, a PE ratio of -0.44 and a beta of 1.00.

About Intellipharmaceutics International

Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.